We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.47%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$405B
AUM Growth
+$3.26B
Cap. Flow
-$4.73B
Cap. Flow %
-1.17%
Top 10 Hldgs %
17.59%
Holding
10,501
New
1,227
Increased
3,693
Reduced
4,131
Closed
1,043

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.12B
2
AAPL icon
Apple
AAPL
+$1.08B
3
MSFT icon
Microsoft
MSFT
+$1.05B
4
NKE icon
Nike
NKE
+$1.03B
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$821M

Sector Composition

Rank Sector Weight
1 Technology 17.8%
2 Financials 8.25%
3 Healthcare 6.4%
4 Consumer Discretionary 5.85%
5 Communication Services 4.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DRTSW icon
8851
Alpha Tau Medical Warrant
DRTSW
$63M
$493 ﹤0.01%
2,431
+2,290
+1,624% +$543
LUX
8852
DELISTED
Tema Luxury ETF
LUX
$493 ﹤0.01%
21
-4
-16% -$98
FORLU
8853
DELISTED
Four Leaf Acquisition Corp Unit
FORLU
$493 ﹤0.01%
45
PTEC
8854
DELISTED
Global X PropTech ETF
PTEC
$491 ﹤0.01%
+16
New +$493
GEVO icon
8855
Gevo
GEVO
$360M
$486 ﹤0.01%
872
-234,546
-100% -$157K
GWH.WS
8856
DELISTED
ESS Tech Inc Warrant
GWH.WS
$485 ﹤0.01%
6,933
+6,876
+12,063% +$477
SMCF icon
8857
Themes US Small Cap Cash Flow Champions ETF
SMCF
$3.23M
$484 ﹤0.01%
+17
New +$493
EUM icon
8858
ProShares Trust Short MSCI Emerging Markets
EUM
$9.65M
$483 ﹤0.01%
18
KVACU icon
8859
Keen Vision Acquisition Corp Units
KVACU
$156M
$471 ﹤0.01%
45
SELV icon
8860
SEI QiM U.S. Large Cap Low Volatility Active ETF
SELV
$257M
$471 ﹤0.01%
17
-66
-80% -$1.79K
BTSGU icon
8861
BrightSpring Health Services Unit
BTSGU
$1.6B
$471 ﹤0.01%
+10
New +$444
KPOP
8862
DELISTED
JAKOTA K-Pop and Korean Entertainment ETF
KPOP
$471 ﹤0.01%
+33
New +$507
BITS icon
8863
Global X Blockchain & Bitcoin Strategy ETF
BITS
$23.1M
$467 ﹤0.01%
7
GHMS
8864
DELISTED
Goose Hollow Multi-Strategy Income ETF
GHMS
$460 ﹤0.01%
18
-10
-36% -$257
SPRU icon
8865
Spruce Power Holding Corp
SPRU
$35.8M
$460 ﹤0.01%
126
+38
+43% +$140
NETDU
8866
DELISTED
Nabors Energy Transition Corp II Unit
NETDU
$454 ﹤0.01%
43
ZSB icon
8867
USCF Sustainable Battery Metals Strategy Fund
ZSB
$2.16M
$453 ﹤0.01%
31
+1
+3% +$16
AMND
8868
DELISTED
ETRACS Alerian Midstream Energy High Dividend Index ETN
AMND
$452 ﹤0.01%
10
VBIV
8869
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$447 ﹤0.01%
678
MNDO icon
8870
Mind CTI
MNDO
$19.4M
$446 ﹤0.01%
240
-1,751
-88% -$3.3K
NPABU
8871
DELISTED
New Providence Acquisition Corp. II Unit
NPABU
$445 ﹤0.01%
+35
New +$445
UPV icon
8872
ProShares Ultra FTSE Europe
UPV
$17M
$435 ﹤0.01%
+7
New +$444
MIDE icon
8873
Xtrackers S&P MidCap 400 ESG ETF
MIDE
$3.41M
$432 ﹤0.01%
+15
New +$433
SPRO icon
8874
Spero Therapeutics
SPRO
$67.7M
$430 ﹤0.01%
331
-5,397
-94% -$8.14K
MITAW
8875
DELISTED
Coliseum Acquisition Corp. Warrant
MITAW
$430 ﹤0.01%
+8,598
New +$451

Similar funds

UBS Group's Q2 2024 Portfolio in Review

As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

UBS Group's Q2 2024 filing shows 1,227 new, 3,693 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
  • UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
  • UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
  • UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
  • UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
  • UBS Group opened 1,227 new positions and closed 1,043 in Q2 2024.
  • UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.